JP2024534892A5 - - Google Patents
Info
- Publication number
- JP2024534892A5 JP2024534892A5 JP2024513940A JP2024513940A JP2024534892A5 JP 2024534892 A5 JP2024534892 A5 JP 2024534892A5 JP 2024513940 A JP2024513940 A JP 2024513940A JP 2024513940 A JP2024513940 A JP 2024513940A JP 2024534892 A5 JP2024534892 A5 JP 2024534892A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence described
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163240216P | 2021-09-02 | 2021-09-02 | |
| US63/240,216 | 2021-09-02 | ||
| PCT/US2022/042451 WO2023034566A1 (en) | 2021-09-02 | 2022-09-02 | Anti-dll3 antibodies and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534892A JP2024534892A (ja) | 2024-09-26 |
| JP2024534892A5 true JP2024534892A5 (cg-RX-API-DMAC7.html) | 2025-09-10 |
Family
ID=85412872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513940A Pending JP2024534892A (ja) | 2021-09-02 | 2022-09-02 | 抗dll3抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240368269A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4396224A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534892A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118159558A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022337142A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3230628A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023034566A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202421189A (zh) * | 2022-08-22 | 2024-06-01 | 美商雅博得樂醫療公司 | 用於標靶性放射性同位素療法之多價免疫結合物 |
| CN121293357A (zh) | 2022-08-22 | 2026-01-09 | 雅博得乐医疗公司 | Dll3结合分子及其用途 |
| WO2025061132A1 (en) * | 2023-09-21 | 2025-03-27 | Concept To Medicine Biotech Co., Ltd. | Anti-dll3 antibodies and uses thereof |
| TW202600599A (zh) * | 2024-03-11 | 2026-01-01 | 大陸商樂普生物科技股份有限公司 | 抗dll3抗體及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2530091T3 (pl) * | 2010-01-29 | 2018-08-31 | Chugai Seiyaku Kabushiki Kaisha | Przeciwciało przeciwko dll3 |
| EP2598532B1 (en) * | 2010-07-30 | 2017-07-12 | Gianluca Moroncini | Epitopes of the human pdgf receptor able to bind human auto-antibodies, antibodies and uses thereof |
| ES2886123T3 (es) * | 2012-01-31 | 2021-12-16 | Regeneron Pharma | Anticuerpos anti-asic1 y usos de los mismos |
| CN107922487A (zh) * | 2015-03-06 | 2018-04-17 | 索伦托治疗有限公司 | 结合jag1的抗体治疗剂 |
| EP3337517A4 (en) * | 2015-08-20 | 2019-04-17 | Abbvie Stemcentrx LLC | ANTI-DLL3 ANTIBODY AGGREGATE CONJUGATES AND METHOD OF USE |
| AU2016332900C1 (en) * | 2015-09-29 | 2024-07-04 | Amgen Inc. | ASGR inhibitors |
| WO2019079762A1 (en) * | 2017-10-20 | 2019-04-25 | Children's National Medical Center | METHODS OF DISCOVERING ANTIBODIES USING TRANSCRIPTOMES AND COMPOSITIONS DERIVED THEREFROM |
| US20220025037A1 (en) * | 2018-04-03 | 2022-01-27 | Dragonfly Therapeutics, Inc. | Antibody variable domains targeting dll3, and use thereof |
| TWI848953B (zh) * | 2018-06-09 | 2024-07-21 | 德商百靈佳殷格翰國際股份有限公司 | 針對癌症治療之多特異性結合蛋白 |
| AU2019414968A1 (en) * | 2018-12-27 | 2021-08-12 | Gigagen, Inc. | Anti-PD-1 binding proteins and methods of use thereof |
| US12441789B2 (en) * | 2019-07-11 | 2025-10-14 | Memorial Sloan Kettering Cancer Center | DLL3-targeting antibodies and uses thereof |
| EP4065601A1 (en) * | 2019-11-25 | 2022-10-05 | Mabloc, LLC | Anti-yellow fever virus antibodies, and methods of their generation and use |
-
2022
- 2022-09-02 JP JP2024513940A patent/JP2024534892A/ja active Pending
- 2022-09-02 CN CN202280071949.3A patent/CN118159558A/zh active Pending
- 2022-09-02 WO PCT/US2022/042451 patent/WO2023034566A1/en not_active Ceased
- 2022-09-02 CA CA3230628A patent/CA3230628A1/en active Pending
- 2022-09-02 EP EP22865604.7A patent/EP4396224A4/en active Pending
- 2022-09-02 AU AU2022337142A patent/AU2022337142A1/en active Pending
-
2024
- 2024-02-28 US US18/589,762 patent/US20240368269A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tang et al. | Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments | |
| JP5110768B2 (ja) | モノクローナル抗体pam4ならびに膵臓癌の診断および治療のためのその使用 | |
| US20200255537A1 (en) | Internalizing human monoclonal antibodies targeting prostate cancer cells in situ | |
| JP5139626B2 (ja) | モノクローナル抗体hPAM4 | |
| US7183388B2 (en) | Anti-MUC-1 single chain antibodies for tumor targeting | |
| AU2016294858B2 (en) | Radiolabelled antibody fragments for use in treating cancer | |
| Spiegelberg et al. | CD44v6‐Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody‐Based Approaches | |
| WO2023034566A1 (en) | Anti-dll3 antibodies and uses thereof | |
| CN119499408A (zh) | 靶向gpc3的分子探针以及用途 | |
| US11396538B2 (en) | Antibodies to centrin-1, methods of making, and uses thereof | |
| WO2025112030A1 (zh) | B7h3结合多肽及其用途 | |
| US20240261446A1 (en) | Anti-cd38 single domain antibodies in disease monitoring and treatment | |
| WO2021229104A1 (en) | Anti-cd38 single-domain antibodies in disease monitoring and treatment | |
| JP5990523B2 (ja) | 抗ヒトトランスフェリン受容体抗体を含む画像用腫瘍診断剤 | |
| US20230190968A1 (en) | Anti-cd38 single-domain antibodies in disease monitoring and treatment | |
| JP2024533162A5 (cg-RX-API-DMAC7.html) | ||
| Shah | Pretargeted Cancer Radioimmunotherapy and Radioimaging Using Antibodies and Antibody Fragments | |
| WO2024244006A1 (zh) | 靶向itga2的抗体、其抗体药物缀合物以及用途 | |
| Li et al. | Anti-MET immunoPET for non-small cell lung cancer using novel fully | |
| Strand et al. | Joanna Strand 1,*, Kjell Sjöström 2, Urpo J. Lamminmaki 3, Oskar Vilhelmsson Timmermand 1 | |
| Tang | Against HER2/neu or Tumor-Associated Glycoprotein-72 | |
| Dijkers | Development of new radiopharmaceutical for molecular imaging in oncology | |
| IL165752A (en) | Chimeric monoclonal antibody pam4, a conjugate comprising it and an antibody comprising the same or fragments thereof |